ACE-031 is a recombinant fusion protein that has been studied in biological research for its interaction with the myostatin signalling pathway, a regulatory system involved in skeletal muscle growth and development.

The compound is designed to bind to myostatin and related ligands within the transforming growth factor-beta (TGF-β) superfamily. Because these signalling pathways influence muscle development and tissue regulation, ACE-031 has been investigated in research environments examining muscle biology, growth regulation, and metabolic signalling processes.

Scientific studies have explored how modulation of the myostatin pathway may affect skeletal muscle physiology and cellular growth mechanisms.

ACE-031: Quick Facts

Chemical Properties & Molecular Data

ACE-031 is not a simple peptide fragment but a recombinant fusion protein. It consists of the extracellular domain of the activin type II receptor (ActRIIB) fused to the Fc portion of human immunoglobulin.

This design allows the molecule to bind to circulating ligands in the TGF-β family, including myostatin and activin proteins, preventing them from interacting with their natural receptors.

Because the TGF-β signalling pathway is involved in regulating muscle growth and cellular development, molecules that interact with these receptors are studied in various areas of biological research.

Mechanism of Action

In laboratory studies, ACE-031 is primarily investigated for its interaction with the myostatin signalling pathway.

Research suggests that ACE-031 may influence:

• myostatin signalling pathways

• activin receptor signalling

• skeletal muscle growth regulation

• TGF-β family ligand interactions

By binding to ligands that normally activate the activin type II receptor, ACE-031 may alter signalling processes involved in muscle development and tissue regulation.

These interactions have made the compound a focus of research exploring the biological control of muscle growth.

Areas of Scientific Research

ACE-031 has been studied in several research areas involving growth regulation and cellular signalling.

Common research topics include:

• skeletal muscle biology

• myostatin signalling pathways

• TGF-β superfamily signalling

• muscle growth regulation

• metabolic signalling related to muscle tissue

These research areas aim to better understand how signalling molecules regulate muscle development and cellular growth processes.

Reconstitution of ACE-031

In laboratory environments, protein-based research compounds are often supplied in lyophilised form to improve stability during storage and transport.

Before use in experimental studies, the compound must be reconstituted into solution using a sterile solvent appropriate for laboratory research.

The solvent is typically introduced slowly along the inner wall of the vial to allow the powder to dissolve gradually. Gentle swirling may assist dissolution, while vigorous agitation is usually avoided in order to maintain protein stability.

Researchers commonly determine the desired concentration before preparing peptide or protein solutions. You can use our Peptide Calculator to estimate dilution ratios and final solution concentrations based on vial strength and solvent volume.

Storage of ACE-031

Proper storage conditions help maintain the stability and structural integrity of protein-based research compounds.

Lyophilised ACE-031 is generally stored in cool, dry laboratory conditions, often under refrigeration or freezing temperatures to preserve stability.

Protecting samples from moisture, light exposure, and temperature fluctuations helps minimise degradation.

After reconstitution, solutions are typically stored at lower temperatures and handled according to standard laboratory practices to maintain sample stability during research experiments.

Summary

ACE-031 is a recombinant fusion protein designed to interact with signalling molecules in the myostatin and TGF-β pathways. In research environments, the compound has been studied for its potential influence on signalling mechanisms involved in muscle development and cellular growth regulation.

Because of its interaction with these pathways, ACE-031 continues to be investigated in studies examining skeletal muscle biology and growth signalling processes.

References

1. Lee, S.J. (2004). Regulation of muscle mass by myostatin.
   https://pubmed.ncbi.nlm.nih.gov/15461742/
2. Attie, K.M., et al. (2013). A single ascending-dose study of ACE-031 in healthy volunteers.
   https://pubmed.ncbi.nlm.nih.gov/23313318/
3. Koncarevic, A., et al. (2012). A novel therapeutic approach to treating muscle wasting using ActRIIB-Fc fusion proteins.
   https://pubmed.ncbi.nlm.nih.gov/22189052/